{'text': 'More UK patients will now be eligible for two costly hepatitis C treatments', 'publisher': {'href': 'https://pharmaceutical-journal.com', 'title': 'The Pharmaceutical Journal'}, 'created_at': 'Fri, 16 Jan 2015 08:00:00 GMT', 'description': 'More UK patients will now be eligible for two costly hepatitis C treatments  The Pharmaceutical Journal', 'url': 'https://news.google.com/rss/articles/CBMiwAFBVV95cUxQazYyLU55MC1PVkJzTERpckw5bWxvVVFJbXZsb2dUb0p4eVRvTWRPNHQ0bWY3VGxOZlhLaVhpS2kxN0R5ZUdROEp3YmVUOUQxbU85T0NLQTd2VER0NlE1VEVZZjB1ZUR4ZVJkc3ZyVDIzTm5WZ0FUTk9leGZxekFRSGxxdmZKSmxqNHF0NjZZcXQwOUxsdWtwSHJWcUJTRm5kbXkyaW5PdDZTbDdqbVZTMDg4R3FjaFJqbjMxLWlmeTU?oc=5&hl=en-US&gl=US&ceid=US:en'}
